Goldman Sachs Group Inc Charles River Laboratories International, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 153,052 shares of CRL stock, worth $28.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,052

Previous 218,356 29.91%

Holding current value

$28.4 Million

Previous $45.1 Million 33.16%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $12.3 Million - $16 Million	-65,304 Reduced 29.91%	153,052 $30.1 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $14.3 Million - $18.6 Million	69,115 Added 46.31%	218,356 $45.1 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $1.05 Million - $1.41 Million	-5,153 Reduced 3.34%	149,241 $40.4 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $1.55 Million - $2.25 Million	-9,422 Reduced 5.75%	154,394 $36.5 Million
Q3 2023 May 14, 2024	BUY	$194.44 - $217.61 $1.83 Million - $2.05 Million	9,422 Added 6.1%	163,816 $32.1 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $23.8 Million - $26.6 Million	-122,168 Reduced 42.72%	163,816 $32.1 Million
Q2 2023 May 14, 2024	BUY	$183.71 - $210.25 $15.1 Million - $17.3 Million	82,445 Added 40.51%	285,984 $60.1 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $15.1 Million - $17.3 Million	82,445 Added 40.51%	285,984 $60.1 Million
Q1 2023 May 14, 2024	BUY	$191.89 - $259.92 $17.6 Million - $23.9 Million	91,804 Added 82.16%	203,539 $41.1 Million
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $17.6 Million - $23.9 Million	91,804 Added 82.16%	203,539 $41.1 Million
Q4 2022 May 14, 2024	SELL	$197.11 - $250.07 $1.31 Million - $1.66 Million	-6,639 Reduced 5.61%	111,735 $24.3 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $1.31 Million - $1.66 Million	-6,639 Reduced 5.61%	111,735 $24.3 Million
Q3 2022 May 14, 2024	SELL	$182.44 - $250.54 $175,324 - $240,768	-961 Reduced 0.81%	118,374 $23.3 Million
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $175,324 - $240,768	-961 Reduced 0.81%	118,374 $23.3 Million
Q2 2022 May 14, 2024	SELL	$204.13 - $302.4 $7.16 Million - $10.6 Million	-35,059 Reduced 22.71%	119,335 $25.5 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $6.59 Million - $9.76 Million	-32,275 Reduced 21.29%	119,335 $25.5 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $7.41 Million - $10.5 Million	29,005 Added 23.66%	151,610 $43.1 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $238,938 - $305,102	-680 Reduced 0.55%	122,605 $46.2 Million
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $45.9 Million - $56.5 Million	123,285 New	123,285 $50.9 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Charles River Laboratories International, Inc. Transaction History